Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence by Masoud Etemadifar, Mehri Salari, Omid Mirmosayyeb, Mehdi Serati, Roham Nikkhah, Mozhde Askari, Emad Fayyazi

Subjects: “…CD20 antibody…”
Get full text

Novel applications of Rituximab in dermatological disorders by Prasan R Bhandari, Varadraj V Pai

Subjects: “…Anti-CD20 antibody…”
Get full text

Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up by Mehrzad Mirzania, Sedigheh Khalili, Akbar Hasanpoor, Ahmad Reza Shamshiri

Subjects: Get full text

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab by Frau J, Coghe G, Lorefice L, Fenu G, Cocco E

Subjects: Get full text

Clinical application of obinutuzumab for treating chronic lymphocytic leukemia by Luan C, Chen B

Subjects: “…CD20 antibody…”
Get full text

Characterization of a Novel Humanized Anti-CD20 Antibody with Potent Anti-Tumor Activity against Non-Hodgkin's Lymphoma by Haifeng Zhang, Liping Song, Hongtu Ye, Lide Hu, Wenlu Liang, Datao Liu

Subjects: Get full text

Novel humanized anti‐CD20 antibody BM‐ca binds to a unique epitope and exerts stronger cellular activity than others by Hideaki Kobayashi, Yuka Matsunaga, Yumiko Uchiyama, Kenji Nagura, Yasuhiko Komatsu

Subjects: “…Anti‐CD20 antibody…”
Get full text

Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders by R Poongodi, Neelam Varma, Shano Naseem, Bose Parveen, Subhash Varma

Subjects: “…CD20 antibody binding capacity…”
Get full text

Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy by Al-Sawaf O, Fischer K, Engelke A, Pflug N, Hallek M, Goede V

Subjects: Get full text

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma by Hui Yu, Xing Wang, Jiao Li, Yingying Ye, Dedao Wang, Wei Fang, Lan Mi, Ning Ding, Xiaogan Wang, Yuqin Song, Jun Zhu

Subjects: “…anti-CD20 antibody…”
Get full text

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression by Oanh T. P. Nguyen, Sandra Lara, Giovanni Ferro, Matthias Peipp, Sandra Kleinau

Subjects: “…anti-CD20 antibody…”
Get full text

Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration by Ruriko Kawanabe, Ayumi Yoshizaki, Kazuki M. Matsuda, Hirohito Kotani, Teruyoshi Hisamoto, Yuta Norimatsu, Ai Kuzumi, Takemichi Fukasawa, Satoshi Ebata, Asako Yoshizaki-Ogawa, Shinichi Sato

Subjects: Get full text

Vaginal delivery with immune thrombocytopenic purpura-induced severe thrombocytopenia by Yu-HsuanChen, Yeu-ChinChen, Cheng-ChangChang, Kuo-MinSu

Subjects: Get full text

Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide by Alexandra Albertsson-Lindblad, Catja Freiburghaus, Mats Jerkeman, Sara Ek

Subjects: Get full text

B-cell depletion therapy for multiple sclerosis by Yusei Miyazaki, Masaaki Niino

Subjects: “…anti-cd20 antibody…”
Get full text

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination by Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Marika Watanabe, Akihito Kitao, Yoshiharu Miyata, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Taiji Koyama, Yoshinori Imamura, Naomi Kiyota, Hiroshi Matsuoka, Yasuko Mori, Hironobu Minami

Subjects: Get full text

Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients by Chutima Seree-aphinan, Yanisa Ratanapokasatit, Poonkiat Suchonwanit, Ploysyne Rattanakaemakorn, Pichaya O-Charoen, Prapaporn Pisitkun, Thanitta Suangtamai, Chavachol Setthaudom, Sonphet Chirasuthat, Kumutnart Chanprapaph

Subjects: Get full text

The causal relationship between anti-CD20 antibodies and endometrial cancer: a Mendelian randomization study by Jinqiu Su, Zhuang Li, Jianli Wang, Nairong Liu, Liyi Bao, Jiayuan Du, Yan Li, Yaojie Yu, He Wang

Subjects: Get full text

Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab by David Totschnig, Daniel Doberer, Renate Haberl, Christoph Wenisch, Arschang Valipour

Subjects: Get full text

Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma by Jiayi Zhang, Minglu Zhong, Weijie Zhong, Yanfei Lan, Zhaohu Yuan, Yuyou Duan, Yaming Wei

Subjects: Get full text